SEC Comment Letter 0000000000-24-003783 to Mind Medicine (MindMed) Inc. (MNMD) (CIK 0001813814) (DFTX)
Mind Medicine (MindMed) Inc. (MNMD) (CIK 0001813814)
Date: April 9, 2024 · CIK: 0001813814 · Accession: 0000000000-24-003783
AI Filing Summary & Sentiment
File numbers found in text: 333-278468
Letter
United States securities and exchange commission logo April 9, 2024 Robert Barrow Chief Executive Officer Mind Medicine (MindMed) Inc. One World Trade Center Suite 8500 New York, NY 10007 Re:Mind Medicine (MindMed) Inc. Registration Statement on Form S-3 Filed April 2, 2024 File No. 333-278468 Dear Robert Barrow: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Lauren Hamill at 303-844-1008 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Steven Abrams
Show Raw Text
United States securities and exchange commission logo
April 9, 2024
Robert Barrow
Chief Executive Officer
Mind Medicine (MindMed) Inc.
One World Trade Center
Suite 8500
New York, NY 10007
Re:Mind Medicine (MindMed) Inc.
Registration Statement on Form S-3
Filed April 2, 2024
File No. 333-278468
Dear Robert Barrow:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Lauren Hamill at 303-844-1008 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Steven Abrams